The company launched a Phase 2 Long COVID study to evaluate whether immune activation with Anktiva can improve recovery by ...

New findings reveal how cancer manipulates immune pathways and highlight therapeutic strategies to unleash T-cells against even the most resistant tumors. Study: Cancer cells impair monocyte-mediated ...

Using a variety of laboratory and animal models, the team found that cysteine fuels the production of the antioxidant ...

SOUTH SAN FRANCISCO, Calif--(BUSINESS WIRE)--Asher Biotherapeutics, Inc. (Asher Bio), a biotechnology company focused on developing therapies to precisely engage specific immune cells to fight cancer, ...

Signaling is fundamental to how cells sense and respond to their environment—but in immune cells, those signals must be ...

CD8 + cytotoxic T lymphocytes (CTLs) serve as central effectors in cancer immunotherapy by directly eliminating tumor cells. However, current clinical therapies face significant limitations. These ...

A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer and infectious diseases, today announced a ...

Are you feeling unmotivated to work out regularly during the COVID-19 pandemic? Do you need a fresh source of daily motivation to stick with an exercise regimen involving cardio and strength-training ...

Immunity is orchestrated by two responses referred to as the innate and adaptive immune systems. Each system works to ...